Close

KRTX and CERE Related Headlines

Go Back

Dec 7, 2023 11:13AM This biotech stock could be the next M&A target after AbbVie's $8.7B deal for Cerevel

KRTX and CERE Related Press Releases

Go Back

KRTX and CERE Related SEC Filings

Go Back